Wednesday , May 18 2022

McGill: Does an intelligent application conduct HIV testing in Canada? | Health


The non-HIV self-assessment strategies have been recommendations by the World Health Organization (WHO) 2016, amongst people who allow HIV to be aware of their situation. Home-based testing kits are still required in Canada for sale. However, the McGill University Health Research Institute (RI-MUHC) and the Clinique Médicale Actuel collaborators, in Montreal, monitored a non-self-defense program for HIV through a mobile phone and tablet application called HIVSmart! Risk population (male men). The findings of the study, first Canadian, have been published this week in Internet Medical Internet Journal.

"To reach 95.95.95 to meet the 95-95-95 targets set by UNAIDS for the year 2030, it is essential to help detect HIV. A false strategy for a momentary diagnosis is HIV self-defense," says Dr. Nitika Pant Pai, principal author of this research and RI-MUHC's Healthcare System Balloon Disease and Immune Researcher, and McGill University Medical Associate Professor. "HIVSmart!" Ties auto-testing to all the gaps in the process, works with any approved HIV self-project, makes it easier for the testers to proactively inform the user. "

"HIVSmart can help reduce the number of people living with HIV," says Dr. Réjean Thomas, researcher, Clinique Médicale L & # 39; Actuel, founder and director of the projection, HIVSmart! . . & # 39; & # 39; An application like GIBSmart! it increases the accessibility to access tests, especially outside big cities, which is sometimes more difficult to obtain confidentiality tests. "

HIVSmart! It is a confidential software application for your phone, tablet or web (Android, iPhone and iPad). Dr. Pant PA and his team have developed with RI-MUHC. It reports, interprets and maintains the confidentiality of the data, but, above all, the user can provide advice or assistance quickly and watch the user can take care of it. Initially with the development of Grand Challenges Canada, GIBSmart! It was evaluated in Montreal through a research funded by the Canadian Health Research Institute (CIHR).

HIVSmart! Montreal feasibility

In July 2016 and February 2017, men with 45 years of age (men between 18 and 73 years of age) were sexually identical to the Clinique Médicale L & # 39; Actuel HIV test. They offered a home-based salivary HIV test and a tablet equipped with GIBSmart. Application The strategy controlled the simulated home environment. Use GpsSmart! Participants were guided by the self-defense process, how to perform and interpret the test, collecting and carefully collecting results.

"Our research shows that GIBSmart! A viable, internationally and preferably viable application strategy is the South American educational population in southern Montreal," says Dr. Pant Pai "As a strategy, people prefer to buy themselves by themselves, such as at the comfort of a private space such as at home, in the office or in a kiosk, which allows it!"

HIV self-testing in risk populations

In Canada, the HIV epidemic is divided into key populations, such as MSM, injection user drugs, indigenous populations and immigrants from endemic HIV-countries. 18% and 25% of external MSM populations do not know the status of positive HIV, and the proportion can be more proportional to IDU, indigenous populations and immigrants, which emphasizes the need for available HIV rehabilitation services.

"Today, we have all the means of eliminating HIV. The GIBSmart! Application is a way of supporting the patient's autonomy," says Dr. Thomas. "Promotion of the projection reduces the number of people who do not know the state of the HIV, because it quickly puts the HIV positive into the treatment, making the virus charge impossible and, ultimately, eradicating HIV."

Researchers have invented HIVSmart! self-testing strategy in many Canadian and worldwide risk populations, thereby maximizing public health impact. HIVSmart! A strategy is also being tested in South Africa.

Strategic monitoring of UNAIDS to end AIDS until 2030:

  • Since the 2030s, 95% of people living with HIV know about HIV.
  • Since the 2030s, 95% of those diagnosed with HIV infection receive permanent antiretroviral therapy.
  • Since the 2030s, 95% of people who receive antiretroviral therapy have a virus breakdown.


Participant profile

  • 84.7% were higher than high school students;
  • 79.5% were occupied;
  • 52.5% have been tested for the last 6 months.

Main results

  • 99.3% of the participants have verified negative tests and made negative tests;
  • 0.7% of the attendees who had a positive self-test and lab-confirmed positive were linked to a physician within the same day;
  • 98.8% of the participants had the application useful;
  • 94% of the participants were advised to a friend or a member.

-MUHC Research Institute

-McGill University Health Center


Source link